CA2440713A1 - Forme posologique orale contenant de la nicotine - Google Patents
Forme posologique orale contenant de la nicotine Download PDFInfo
- Publication number
- CA2440713A1 CA2440713A1 CA002440713A CA2440713A CA2440713A1 CA 2440713 A1 CA2440713 A1 CA 2440713A1 CA 002440713 A CA002440713 A CA 002440713A CA 2440713 A CA2440713 A CA 2440713A CA 2440713 A1 CA2440713 A1 CA 2440713A1
- Authority
- CA
- Canada
- Prior art keywords
- nicotine
- dosage form
- active
- sugar alcohol
- oral administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne des formes posologiques solides à administration orale, comprenant une matrice vitreuse, qui sont utiles pour l'administration par voie transmucosale orale d'un principe actif de nicotine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27860601P | 2001-03-26 | 2001-03-26 | |
US60/278,606 | 2001-03-26 | ||
PCT/US2002/008914 WO2002076211A1 (fr) | 2001-03-26 | 2002-03-22 | Forme posologique orale contenant de la nicotine |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2440713A1 true CA2440713A1 (fr) | 2002-10-03 |
Family
ID=23065632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002440713A Abandoned CA2440713A1 (fr) | 2001-03-26 | 2002-03-22 | Forme posologique orale contenant de la nicotine |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1372392A4 (fr) |
JP (1) | JP2004525928A (fr) |
CN (2) | CN101301275A (fr) |
AR (1) | AR033444A1 (fr) |
AU (1) | AU2002252470B2 (fr) |
BR (1) | BR0208382A (fr) |
CA (1) | CA2440713A1 (fr) |
MX (1) | MXPA03008762A (fr) |
NZ (1) | NZ528167A (fr) |
PL (1) | PL364621A1 (fr) |
WO (1) | WO2002076211A1 (fr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040253307A1 (en) * | 2003-02-04 | 2004-12-16 | Brian Hague | Sugar-free oral transmucosal solid dosage forms and uses thereof |
IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
PT1648421T (pt) * | 2003-07-24 | 2017-12-22 | Glaxosmithkline Llc | Películas de dissolução oral |
GB0320854D0 (en) | 2003-09-05 | 2003-10-08 | Arrow No 7 Ltd | Buccal drug delivery |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
EP1691631A4 (fr) | 2003-11-07 | 2012-09-05 | Us Smokeless Tobacco Co | Compositions a base de tabac |
US8097271B2 (en) * | 2004-08-11 | 2012-01-17 | Kraft Foods Global Brands Llc | Warming compositions and delivery systems therefor |
AU2005284908B2 (en) | 2004-09-13 | 2011-12-08 | Morningside Venture Investments Limited | Biosynchronous transdermal drug delivery |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
WO2008069921A2 (fr) * | 2006-12-01 | 2008-06-12 | Cima Labs Inc. | Forme de dosage à base de nicotine pour administration par voie orale transmuqueuse |
US7718677B2 (en) | 2007-04-02 | 2010-05-18 | Parkinson's Institute | Methods and compositions for reduction of side effects of therapeutic treatments |
GB2468424B (en) * | 2007-04-02 | 2011-11-09 | Parkinson S Inst | Methods and compositions for reduction of side effects of therapeutic treatments |
DE102008012015A1 (de) * | 2008-03-01 | 2009-09-10 | Südzucker AG Mannheim/Ochsenfurt | Verbesserte Isomalt-haltige Komprimate und Verfahren zu ihrer Herstellung |
KR20130008535A (ko) * | 2010-02-18 | 2013-01-22 | 자틴 바산트 타카르 | 니코틴을 함유하는 소프트 젤라틴 알약 |
US20110274628A1 (en) * | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
UA112974C2 (uk) | 2010-09-16 | 2016-11-25 | Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид | Нікотиновмісна композиція (варіанти) |
EP2729148A4 (fr) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | Compositions et méthodes de traitement de symptômes chez des patients atteints de la maladie de parkinson |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US9044035B2 (en) * | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
TW201507726A (zh) * | 2013-05-10 | 2015-03-01 | Glaxosmithkline Llc | 菸鹼菱形錠配製物 |
CN104132895B (zh) * | 2014-07-08 | 2017-08-25 | 国家烟草质量监督检验中心 | 适用于连续流动法测定烟草及烟草制品中总植物碱的缓冲体系 |
JP2018511355A (ja) | 2015-01-28 | 2018-04-26 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 薬剤送達方法及びシステム |
EP3267875A4 (fr) | 2015-03-12 | 2018-12-05 | Chrono Therapeutics Inc. | Système d'entrée d'état de manque et de support |
JP2020503950A (ja) | 2017-01-06 | 2020-02-06 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 経皮薬剤送達の装置及び方法 |
SE541358C2 (en) * | 2017-05-30 | 2019-08-13 | Enorama Pharma Ab | Nicotine-containing chewing gum compositions |
AU2019279884A1 (en) | 2018-05-29 | 2020-12-10 | Morningside Venture Investments Limited | Drug delivery methods and systems |
AU2021207268A1 (en) * | 2020-01-15 | 2022-09-08 | Mcneil Ab | Lozenge |
US20220313678A1 (en) * | 2021-04-06 | 2022-10-06 | Altria Client Services Llc | Spray dried nicotine for inclusion in oral products |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9310412D0 (en) * | 1993-05-20 | 1993-07-07 | Danbiosyst Uk | Nasal nicotine system |
US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
DE19536394A1 (de) * | 1995-09-29 | 1997-04-03 | Basf Ag | Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze |
DE19639342C2 (de) * | 1996-09-25 | 1998-07-16 | Suedzucker Ag | Kaugummi, enthaltend ein Süßungsmittel |
US6322806B1 (en) * | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
-
2002
- 2002-03-22 CA CA002440713A patent/CA2440713A1/fr not_active Abandoned
- 2002-03-22 MX MXPA03008762A patent/MXPA03008762A/es active IP Right Grant
- 2002-03-22 JP JP2002574739A patent/JP2004525928A/ja active Pending
- 2002-03-22 NZ NZ528167A patent/NZ528167A/en not_active IP Right Cessation
- 2002-03-22 AR ARP020101068A patent/AR033444A1/es unknown
- 2002-03-22 BR BR0208382-5A patent/BR0208382A/pt not_active IP Right Cessation
- 2002-03-22 PL PL02364621A patent/PL364621A1/xx not_active Application Discontinuation
- 2002-03-22 CN CNA2008101253651A patent/CN101301275A/zh active Pending
- 2002-03-22 WO PCT/US2002/008914 patent/WO2002076211A1/fr active IP Right Grant
- 2002-03-22 CN CNA028073339A patent/CN1553771A/zh active Pending
- 2002-03-22 EP EP02721544A patent/EP1372392A4/fr not_active Withdrawn
- 2002-03-22 AU AU2002252470A patent/AU2002252470B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP2004525928A (ja) | 2004-08-26 |
MXPA03008762A (es) | 2004-02-18 |
AR033444A1 (es) | 2003-12-17 |
WO2002076211A1 (fr) | 2002-10-03 |
NZ528167A (en) | 2005-04-29 |
BR0208382A (pt) | 2004-06-15 |
AU2002252470B2 (en) | 2008-05-22 |
EP1372392A4 (fr) | 2004-06-23 |
CN1553771A (zh) | 2004-12-08 |
PL364621A1 (en) | 2004-12-13 |
EP1372392A1 (fr) | 2004-01-02 |
CN101301275A (zh) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002252470B2 (en) | Nicotine-containing oral dosage form | |
US20040101543A1 (en) | Nicotine-containing oral dosage form | |
AU2003267268B2 (en) | Modified release oral dosage form | |
AU2002252470A1 (en) | Nicotine-containing oral dosage form | |
US20210093563A1 (en) | Medicinal delivery system and related methods | |
CA2652499C (fr) | Produit pharmaceutique destine a une administration intrabuccale de nicotine comprenant du trometamol servant d'agent tampon | |
KR20100017820A (ko) | 아미노산으로 완충된 경구 니코틴 제형 | |
CA2685456A1 (fr) | Formulation nicotinique orale enrobee, tamponnee aux acides amines | |
NZ529780A (en) | A coated nicotine-containing chewing gum, manufacture and use thereof | |
AU776019B2 (en) | Medicated chewing gum delivery system for nicotine | |
EP1429770B1 (fr) | Nouvelles formulations et leur utilisation | |
AU2008202048A1 (en) | Nicotine-containing oral dosage form | |
AU2002334523A1 (en) | New formulations and use thereof | |
AU2012241150B2 (en) | Medicinal delivery system and related methods | |
CA2109895A1 (fr) | Preparation orale contenant de la nicotine | |
JUNO et al. | PHARMACEUTICAL SCIENCES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |